Atmosphere1 / Shutterstock.com
6 February 2025NewsAmericasMarisa Woutersen

Fed Circ raises ‘gamesmanship’ fears in rare patent term dispute

Oral hearings heard the USPTO side with MSD (Merck) over a term extension for a reissued patent, in a case set to have huge implications for pharma market exclusivity, reports Marisa Woutersen.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
8 August 2023   US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.
Biotechnology
16 May 2024   Puritan Medical argued it had immunity under PREP Act in patent suit | Fed Circ said the district court had not conclusively determined any issue.

More on this story

Big Pharma
8 August 2023   US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.
Biotechnology
16 May 2024   Puritan Medical argued it had immunity under PREP Act in patent suit | Fed Circ said the district court had not conclusively determined any issue.

More on this story

Big Pharma
8 August 2023   US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.
Biotechnology
16 May 2024   Puritan Medical argued it had immunity under PREP Act in patent suit | Fed Circ said the district court had not conclusively determined any issue.